BioMarin Pharmaceutical Inc. - Company Profile and SWOT Analysis
Summary
BioMarin Pharmaceutical Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
BioMarin Pharmaceutical Inc. (BioMarin or 'the company') is a biotechnology company, that is engaged in development and commercialization of biopharmaceuticals for the treatment of rare diseases and medical conditions. The company manufactures pharmaceuticals for treatment of serious diseases and medical conditions such as late infantile neuronal ceroid lipofuscinosis (CLN2), Kyndrisa (drisapersen), Duchenne muscular dystrophy (DMD), achondroplasia, phenylketonuria (PKU), and hemophilia A. BioMarin markets its products under the brands, BioMarin, Brineura, Kuvan, Naglazyme, Palynziq, Roctavian, Vimizim, Voxzogo, and Aldurazyme. It operates in the US, Europe, Latin America, and other regions of the world. The company is headquartered in San Rafael, California, the US.
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook